Vaccination With OK-432 Followed by TC-1 Tumor Lysate Leads to Significant Antitumor Effects-Reference-Cited by-同舟云学术

Vaccination With OK-432 Followed by TC-1 Tumor Lysate Leads to Significant Antitumor Effects

Published:2011-02-14 Issue:7 Volume:18 Page:687-694
ISSN:1933-7191
Container-title:Reproductive Sciences
language:en
Short-container-title:Reprod Sci

Author:

Chen I-Ju¹²,Yen Chih-Feng¹³,Lin Kun-Ju³,Lee Chyi-Long¹,Soong Yung-Kuei¹,Lai Chyong-Huey¹,Lin Cheng-Tao¹⁴

Affiliation:

1. Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Tao-Yuan, Taiwan

2. Department of Traditional Chinese Medicine, Chang Gung Memorial Hospital, Tao-Yuan, Taiwan

3. Department of Nuclear Medicine and Molecular Imaging Center, Chang Gung Memorial Hospital, Tao-Yuan, Taiwan

4. Chang Gung Memorial Hospital and Chang Gung University; and Graduate Institute of Clinical Medical Sciences, Chang Gung University School of medicine, Tao-Yuan, Taiwan

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynaecology

Link

http://journals.sagepub.com/doi/pdf/10.1177/1933719110396230

Reference34 articles.

1. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

2. Global Cancer Statistics, 2002

3. Streptococcal preparation OK432 promotes functional maturation of human monocyte-derived dendritic cells

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liposomes as tunable platform to decipher the antitumor immune response triggered by TLR and NLR agonists;European Journal of Pharmaceutics and Biopharmaceutics;2020-07

2. Immunotherapy with subcutaneous injection of immunomodulatory agent (OK-432) elicits durable response in locally advanced or relapsed cervical cancer;Gynecology and Minimally Invasive Therapy;2019

3. Combined Immunotherapy (OK-432, IL-2) With Chemotherapy Decrease the Recurrence Rate in Advanced Ovarian Cancer;Reproductive Sciences;2018-04-15

4. Vaccination with FasL-/TCL plus MHSP65 induces improved anti-lung cancer immunity in mice;International Immunopharmacology;2018-02

5. Inï¿½vivo antitumor activity evaluation of cancer vaccines prepared by various antigen forms in a murine hepatocellular carcinoma model;Oncology Letters;2017-10-11